Back to Trades
CODE KENNETH REAY
Chief Science OfficerDirectorCIK 0001370684
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
CODE KENNETH REAY, Chief Science Officer, Director, has filed 6 SEC reports (2025–2026), all concentrated in BIOLARGO, INC. (BLGO), totaling $213.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 2 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $45.3K |
| Jul 7 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $60.4K |
| Apr 2 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $11.2K |
| Jan 5 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $10.1K |
| Nov 17 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $50.2K |
| Jul 16 | BLGO BIOLARGO, INC. | CODE KENNETH REAY | Chief Science Officer, Director | Grant | $36.3K |
6 filings